ELLINGTON MANAGEMENT GROUP LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 166 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$403,000
+32.6%
26,000
+67.7%
0.07%
+231.8%
Q1 2018$304,000
-65.7%
15,500
-77.3%
0.02%
-26.7%
Q1 2017$886,000
+14.0%
68,400
+6.4%
0.03%
-86.0%
Q3 2016$777,000
+447.2%
64,300
+328.7%
0.21%
+250.8%
Q1 2016$142,000
-35.7%
15,000
-8.9%
0.06%
-1.6%
Q3 2015$221,000
+87.3%
16,472
+35.0%
0.06%
+59.0%
Q4 2014$118,000
-13.9%
12,200
-12.2%
0.04%
-39.1%
Q2 2014$137,000
-63.0%
13,900
-58.5%
0.06%
-8.6%
Q3 2013$370,00033,5000.07%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders